Oncovita | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

26 results for “Oncovita”

Trials

View all 17 →

ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint)

50 participants · First posted Nov 28, 2017

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

22 participants · First posted Nov 5, 2009

Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome

43 participants · First posted Jul 28, 2010

Drugs

Oncolytic virotherapy; genetically modified measles virus (RNA virus)

MVdeltaC

Manufacturer: Oncovita

Conditions: mesothelioma, bladder cancer +2 more

Fascin Inhibitors(Novita Pharmaceuticals )

Hepatitis C virus therapies(Novita Healthcare/CSIRO)

Organizations

OncoVista, Inc.

United States

Oncovir, Inc.

United States

Novita Pharmaceuticals, Inc.

United States

News

Oncovita Receives FDA Orphan Drug Designation for Oncolytic Measles Virus Therapy in Pleural Mesothelioma

Oncovita Unveils Promising Preclinical Data for MVdeltaC, a Modified Measles Virus Immunotherapy, at EACR 2026

Page 1 of 3